This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in Plains GP (PAGP): Can Its 6.1% Jump Turn into More Strength?
by Zacks Equity Research
Plains GP (PAGP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PAGPNegative Net Change MPLXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arc Resources (AETUF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AETUFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CPRXNegative Net Change IONSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Plains All American (PAA) Soars 6.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Plains All American (PAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PAANegative Net Change DKLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Matthews International (MATW) Surges 14.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Matthews International (MATW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MATWNegative Net Change CSVNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in CS Disco (LAW): Can Its 5.3% Jump Turn into More Strength?
by Zacks Equity Research
CS Disco (LAW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LAWNegative Net Change ZMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Phreesia (PHR) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PHRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Asure Software (ASUR) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Asure Software (ASUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ASURNegative Net Change VIPSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?
by Zacks Equity Research
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MRNANegative Net Change RCUSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?
by Zacks Equity Research
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NVAXNegative Net Change TARSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PENNegative Net Change IQVNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in SpringWorks Therapeutics (SWTX): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
SpringWorks Therapeutics (SWTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NRIXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in SkyWater Technology (SKYT): Can Its 8.3% Jump Turn into More Strength?
by Zacks Equity Research
SkyWater Technology (SKYT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SKYTNegative Net Change AMATNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Paycor HCM (PYCR) Soars 23.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Paycor HCM (PYCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
PANWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nova Ltd. (NVMI) Soars 4.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nova Ltd. (NVMI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NVMIPositive Net Change RMBSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Fiverr (FVRR) Moves 5.5% Higher: Will This Strength Last?
by Zacks Equity Research
Fiverr (FVRR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
FVRRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ADTRAN Holdings (ADTN) Soars 7.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
ADTRAN Holdings (ADTN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ADTNNegative Net Change ECVTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Inari Medical (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
TNDMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
MP Materials (MP) Moves 12.4% Higher: Will This Strength Last?
by Zacks Equity Research
MP Materials (MP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
MPPositive Net Change CLFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
by Zacks Equity Research
ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PDEXPositive Net Change STAANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Gilat (GILT): Can Its 9.8% Jump Turn into More Strength?
by Zacks Equity Research
Gilat (GILT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GILTNegative Net Change GSATPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Luminar Technologies (LAZR) Soars 27.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Luminar Technologies (LAZR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LAZRNegative Net Change VCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Carvana (CVNA): Can Its 6.6% Jump Turn into More Strength?
by Zacks Equity Research
Carvana (CVNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CVNAPositive Net Change MELINegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
GeneDx Holdings (WGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
WGSNegative Net Change ALHCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GHPositive Net Change ACLXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today